Selected research
Market Structure
Global Huoliyuan Pian Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Huoliyuan Pian market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Huoliyuan Pian is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Huoliyuan Pian is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Huoliyuan Pian is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Huoliyuan Pian is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Huoliyuan Pian include Zhengzhou Handu Pharmaceutical Group Co., Ltd., Changbaishan Pharmaceutical Co., Ltd., Xi'an Renren Pharmaceutical Co., Ltd., Tonghua Jinma Pharmaceutical Group Co., Ltd., Tonghua Heping Pharmaceutical Co., Ltd., Tianjin Hezhi Pharmaceutical Group Co., Ltd., Taihua Natural Biopharmaceutical Co., Ltd., Shijiazhuang Dongfang Pharmaceutical Co., Ltd. and Shaanxi Dongtai Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Huoliyuan Pian market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Huoliyuan Pian and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Huoliyuan Pian sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Huoliyuan Pian market size, projected growth trends, production technologies, key applications, and end-use industries.
Huoliyuan Pian Segment by Company
Zhengzhou Handu Pharmaceutical Group Co., Ltd.
Changbaishan Pharmaceutical Co., Ltd.
Xi'an Renren Pharmaceutical Co., Ltd.
Tonghua Jinma Pharmaceutical Group Co., Ltd.
Tonghua Heping Pharmaceutical Co., Ltd.
Tianjin Hezhi Pharmaceutical Group Co., Ltd.
Taihua Natural Biopharmaceutical Co., Ltd.
Shijiazhuang Dongfang Pharmaceutical Co., Ltd.
Shaanxi Dongtai Pharmaceutical Co., Ltd.
Jilin Fusong Pharmaceutical Co., Ltd.
Jilin Gaomiao Pharmaceutical Co., Ltd.
Huoliyuan Pian Segment by Type
0.25g
0.3g
Other
Huoliyuan Pian Segment by Application
Hospital
Clinic
Other
Huoliyuan Pian Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Huoliyuan Pian market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Huoliyuan Pian and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Huoliyuan Pian.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Huoliyuan Pian market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Huoliyuan Pian manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Huoliyuan Pian in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Huoliyuan Pian in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 0.25g
- 0.3g
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Zhengzhou Handu Pharmaceutical Group Co., Ltd.
- Changbaishan Pharmaceutical Co., Ltd.
- Xi'an Renren Pharmaceutical Co., Ltd.
- Tonghua Jinma Pharmaceutical Group Co., Ltd.
- Tonghua Heping Pharmaceutical Co., Ltd.
- Tianjin Hezhi Pharmaceutical Group Co., Ltd.
- Taihua Natural Biopharmaceutical Co., Ltd.
- Shijiazhuang Dongfang Pharmaceutical Co., Ltd.
- Shaanxi Dongtai Pharmaceutical Co., Ltd.
- Jilin Fusong Pharmaceutical Co., Ltd.
- Jilin Gaomiao Pharmaceutical Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Huoliyuan Pian Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Huoliyuan Pian Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Huoliyuan Pian Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Huoliyuan Pian Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Huoliyuan Pian Market Dynamics
- 2.1 Huoliyuan Pian Industry Trends
- 2.2 Huoliyuan Pian Industry Drivers
- 2.3 Huoliyuan Pian Industry Opportunities and Challenges
- 2.4 Huoliyuan Pian Industry Restraints
3 Huoliyuan Pian Market by Manufacturers
- 3.1 Global Huoliyuan Pian Revenue by Manufacturers (2021-2026)
- 3.2 Global Huoliyuan Pian Sales by Manufacturers (2021-2026)
- 3.3 Global Huoliyuan Pian Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Huoliyuan Pian Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Huoliyuan Pian Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Huoliyuan Pian Manufacturers, Product Type & Application
- 3.7 Global Huoliyuan Pian Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Huoliyuan Pian Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Huoliyuan Pian Players Market Share by Revenue in 2025
- 3.8.3 2025 Huoliyuan Pian Tier 1, Tier 2, and Tier 3
4 Huoliyuan Pian Market by Type
- 4.1 Huoliyuan Pian Type Introduction
- 4.1.1 0.25g
- 4.1.2 0.3g
- 4.1.3 Other
- 4.2 Global Huoliyuan Pian Sales by Type
- 4.2.1 Global Huoliyuan Pian Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Huoliyuan Pian Sales by Type (2021-2032)
- 4.2.3 Global Huoliyuan Pian Sales Market Share by Type (2021-2032)
- 4.3 Global Huoliyuan Pian Revenue by Type
- 4.3.1 Global Huoliyuan Pian Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Huoliyuan Pian Revenue by Type (2021-2032)
- 4.3.3 Global Huoliyuan Pian Revenue Market Share by Type (2021-2032)
5 Huoliyuan Pian Market by Application
- 5.1 Huoliyuan Pian Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Huoliyuan Pian Sales by Application
- 5.2.1 Global Huoliyuan Pian Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Huoliyuan Pian Sales by Application (2021-2032)
- 5.2.3 Global Huoliyuan Pian Sales Market Share by Application (2021-2032)
- 5.3 Global Huoliyuan Pian Revenue by Application
- 5.3.1 Global Huoliyuan Pian Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Huoliyuan Pian Revenue by Application (2021-2032)
- 5.3.3 Global Huoliyuan Pian Revenue Market Share by Application (2021-2032)
6 Global Huoliyuan Pian Sales by Region
- 6.1 Global Huoliyuan Pian Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Huoliyuan Pian Sales by Region (2021-2032)
- 6.2.1 Global Huoliyuan Pian Sales by Region (2021-2026)
- 6.2.2 Global Huoliyuan Pian Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Huoliyuan Pian Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Huoliyuan Pian Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Huoliyuan Pian Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Huoliyuan Pian Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Huoliyuan Pian Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Huoliyuan Pian Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Huoliyuan Pian Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Huoliyuan Pian Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Huoliyuan Pian Revenue by Region
- 7.1 Global Huoliyuan Pian Revenue by Region
- 7.1.1 Global Huoliyuan Pian Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Huoliyuan Pian Revenue by Region (2021-2026)
- 7.1.3 Global Huoliyuan Pian Revenue by Region (2027-2032)
- 7.1.4 Global Huoliyuan Pian Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Huoliyuan Pian Revenue (2021-2032)
- 7.2.2 North America Huoliyuan Pian Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Huoliyuan Pian Revenue (2021-2032)
- 7.3.2 Europe Huoliyuan Pian Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Huoliyuan Pian Revenue (2021-2032)
- 7.4.2 Asia-Pacific Huoliyuan Pian Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Huoliyuan Pian Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Huoliyuan Pian Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Zhengzhou Handu Pharmaceutical Group Co., Ltd.
- 8.1.1 Zhengzhou Handu Pharmaceutical Group Co., Ltd. Company Information
- 8.1.2 Zhengzhou Handu Pharmaceutical Group Co., Ltd. Business Overview
- 8.1.3 Zhengzhou Handu Pharmaceutical Group Co., Ltd. Huoliyuan Pian Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Zhengzhou Handu Pharmaceutical Group Co., Ltd. Huoliyuan Pian Product Portfolio
- 8.1.5 Zhengzhou Handu Pharmaceutical Group Co., Ltd. Recent Developments
- 8.2 Changbaishan Pharmaceutical Co., Ltd.
- 8.2.1 Changbaishan Pharmaceutical Co., Ltd. Company Information
- 8.2.2 Changbaishan Pharmaceutical Co., Ltd. Business Overview
- 8.2.3 Changbaishan Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Changbaishan Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 8.2.5 Changbaishan Pharmaceutical Co., Ltd. Recent Developments
- 8.3 Xi'an Renren Pharmaceutical Co., Ltd.
- 8.3.1 Xi'an Renren Pharmaceutical Co., Ltd. Company Information
- 8.3.2 Xi'an Renren Pharmaceutical Co., Ltd. Business Overview
- 8.3.3 Xi'an Renren Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Xi'an Renren Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 8.3.5 Xi'an Renren Pharmaceutical Co., Ltd. Recent Developments
- 8.4 Tonghua Jinma Pharmaceutical Group Co., Ltd.
- 8.4.1 Tonghua Jinma Pharmaceutical Group Co., Ltd. Company Information
- 8.4.2 Tonghua Jinma Pharmaceutical Group Co., Ltd. Business Overview
- 8.4.3 Tonghua Jinma Pharmaceutical Group Co., Ltd. Huoliyuan Pian Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Tonghua Jinma Pharmaceutical Group Co., Ltd. Huoliyuan Pian Product Portfolio
- 8.4.5 Tonghua Jinma Pharmaceutical Group Co., Ltd. Recent Developments
- 8.5 Tonghua Heping Pharmaceutical Co., Ltd.
- 8.5.1 Tonghua Heping Pharmaceutical Co., Ltd. Company Information
- 8.5.2 Tonghua Heping Pharmaceutical Co., Ltd. Business Overview
- 8.5.3 Tonghua Heping Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Tonghua Heping Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 8.5.5 Tonghua Heping Pharmaceutical Co., Ltd. Recent Developments
- 8.6 Tianjin Hezhi Pharmaceutical Group Co., Ltd.
- 8.6.1 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Company Information
- 8.6.2 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Business Overview
- 8.6.3 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Huoliyuan Pian Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Huoliyuan Pian Product Portfolio
- 8.6.5 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Recent Developments
- 8.7 Taihua Natural Biopharmaceutical Co., Ltd.
- 8.7.1 Taihua Natural Biopharmaceutical Co., Ltd. Company Information
- 8.7.2 Taihua Natural Biopharmaceutical Co., Ltd. Business Overview
- 8.7.3 Taihua Natural Biopharmaceutical Co., Ltd. Huoliyuan Pian Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Taihua Natural Biopharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 8.7.5 Taihua Natural Biopharmaceutical Co., Ltd. Recent Developments
- 8.8 Shijiazhuang Dongfang Pharmaceutical Co., Ltd.
- 8.8.1 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Company Information
- 8.8.2 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Business Overview
- 8.8.3 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 8.8.5 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Recent Developments
- 8.9 Shaanxi Dongtai Pharmaceutical Co., Ltd.
- 8.9.1 Shaanxi Dongtai Pharmaceutical Co., Ltd. Company Information
- 8.9.2 Shaanxi Dongtai Pharmaceutical Co., Ltd. Business Overview
- 8.9.3 Shaanxi Dongtai Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Shaanxi Dongtai Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 8.9.5 Shaanxi Dongtai Pharmaceutical Co., Ltd. Recent Developments
- 8.10 Jilin Fusong Pharmaceutical Co., Ltd.
- 8.10.1 Jilin Fusong Pharmaceutical Co., Ltd. Company Information
- 8.10.2 Jilin Fusong Pharmaceutical Co., Ltd. Business Overview
- 8.10.3 Jilin Fusong Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Jilin Fusong Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 8.10.5 Jilin Fusong Pharmaceutical Co., Ltd. Recent Developments
- 8.11 Jilin Gaomiao Pharmaceutical Co., Ltd.
- 8.11.1 Jilin Gaomiao Pharmaceutical Co., Ltd. Company Information
- 8.11.2 Jilin Gaomiao Pharmaceutical Co., Ltd. Business Overview
- 8.11.3 Jilin Gaomiao Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Jilin Gaomiao Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 8.11.5 Jilin Gaomiao Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Huoliyuan Pian Value Chain Analysis
- 9.1.1 Huoliyuan Pian Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Huoliyuan Pian Production Mode & Process
- 9.2 Huoliyuan Pian Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Huoliyuan Pian Distributors
- 9.2.3 Huoliyuan Pian Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst